Cargando…
Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita
Because of the morbidity and limited therapeutic options of autoimmune diseases, there is a high, and thus far, unmet medical need for development of novel treatments. Pemphigoid diseases, such as epidermolysis bullosa acquisita (EBA), are prototypical autoimmune diseases that are caused by autoanti...
Autores principales: | Samavedam, Unni K., Mitschker, Nina, Kasprick, Anika, Bieber, Katja, Schmidt, Enno, Laskay, Tamás, Recke, Andreas, Goletz, S., Vidarsson, Gestur, Schulze, Franziska S., Armbrust, Mikko, Schulze Dieckhoff, Katharina, Pas, Hendri H., Jonkman, Marcel F., Kalies, Kathrin, Zillikens, Detlef, Gupta, Yask, Ibrahim, Saleh M., Ludwig, Ralf J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818881/ https://www.ncbi.nlm.nih.gov/pubmed/29497423 http://dx.doi.org/10.3389/fimmu.2018.00249 |
Ejemplares similares
-
T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita
por: Bieber, Katja, et al.
Publicado: (2016) -
Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita
por: Zillikens, Hannah, et al.
Publicado: (2021) -
Epidermolysis Bullosa Acquisita: The 2019 Update
por: Koga, Hiroshi, et al.
Publicado: (2019) -
Treatment with anti‐neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice
por: Kasprick, Anika, et al.
Publicado: (2020) -
Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita
por: Koga, Hiroshi, et al.
Publicado: (2018)